1Records. Gemma will keep accurate books and records of all Licensed Products developed, manufactured, used, or sold and all Sublicenses, collaboration agreements and joint venture agreements entered into by Gemma that involve Passage Technology. Xxxxx will preserve these books and records for at least [*] from the date of the Financial Report to which they pertain. Upon reasonable notice, key personnel, books, and records will be made reasonably available and will be open to examination by representatives or agents of Passage or Penn during regular office hours to determine their accuracy and assess Xxxxx’s compliance with the terms of this Agreement and the UPenn Agreement; provided that Gemma shall not have an obligation to provide access more than once in any given [*] period to Passage.
1Records. Licensee shall keep, and shall require that each Sublicensee keep, full, true and accurate books of account containing the particulars of its Net Sales and the calculation of royalties. Licensee and its Sublicensees shall each keep such books of account and the supporting data and other records at its principal place of business. Such books and records must be maintained available for examination in accordance with this Section 5.3.1 for five (5) calendar years after the end of the calendar year to which they pertain, and otherwise as reasonably required to comply with GAAP.
1Records. Each party Party shall keep such records as may be needed to afford a clear history of the various deliveries of electric energy made by one party Party to the other and of the hourly integrated demands in kilowatts kiloWatts delivered by one party Party to the other. In maintaining such records, the parties shall effect such segregations and allocations of capacity and energy into classes representing various services and conditions as may be needed in connection with settlements under this Agreement. When and to the extent requested, copies of the records shall be delivered promptly to the other partyParty.
1Records. Otsuka shall maintain complete and accurate records of all Development and other scientific activities conducted by or on behalf of it in connection with each Licensed Product (other than Authorized Generic Products), including all data and other information resulting from such activities (which records shall include, as applicable, books, records, reports, research notes, charts, graphs, comments, computations, analyses, recordings, photographs, computer programs and documentation thereof (e.g., samples of materials and other graphic or written data generated in connection with such Development and scientific activities)), in sufficient detail and in sound scientific manner appropriate for patent and regulatory purposes, which shall fully and properly reflect all work done and results achieved in the performance of the Development activities and Clinical Studies with respect to each Licensed Product (other than Authorized Generic Products) by Otsuka.
1Records. (a) GCO shall create and maintain copies of accurate, complete, reliable and current (up to date) Records necessary for the effective and efficient performance of its obligations under this Agreement including:
(i) such documents, Records and other information required by Applicable Law and the provisions of this Agreement;
(ii) detailed, accurate, complete and current financial Records regarding the Manufacture of Branded Products during the Term; and
(iii) such documents, designs, specifications, configurations, Records and other information relating to GCO’s use, display, reproduction or other exploitation of the Customer IP pursuant to this Agreement; and
(iv) such other additional documents, books, Records and other information as may be mutually agreed to in writing from time to time by the Designated Representatives of the Parties.
(b) GCO shall, and shall cause its applicable affiliates and representatives to, retain accurate and complete copies of all Records for such period of time: (i) as required by Applicable Law; or (ii) until six (6) months after the expiration or termination of this Agreement, whichever is greater (the "Retention Period").
(c) At any time, and from time to time, during the Term and the Retention Period, Customer may make a written request for a copy of the Records created and maintained by GCO (a "Records Request"). GCO shall provide the requested Records as soon as reasonably practicable after the date of its receipt of the Records Request and, in any event, no later than thirty (30) Business Days after its receipt of the Records Request.
1Records. Distributor shall keep accurate records: (i) of its sales efforts, promotional and marketing activities performed under this Agreement; and (ii) in sufficient detail to enable MSD to determine the correctness of any report made under this Agreement, as well as to verify Distributor’s compliance with the other terms of this Agreement (collectively the “Records”). In addition, Distributor shall keep accurate Records in sufficient detail to enable MSD to trace Products distributed in the event of a recall of the Products.
1Records. Each Party shall maintain complete and accurate records of all work conducted pursuant to each Collaboration Program and all results, data and developments made in furtherance thereof, and shall retain such records in accordance with its record retention policy and Law (including, to the extent applicable, GMP, GLP and GCP). Such records shall be in sufficient detail and in good scientific manner appropriate for accounting, patent and regulatory purposes, including demonstrating Documented Lineage. During the Research Term, each Party shall provide the other Party (through the appropriate Working Group and in a form acceptable to the JSC) with quarterly written reports of the work performed under such Collaboration Program and the results achieved by such reporting Party and shall also promptly notify the other Party of any significant data, activities or events that occur under the applicable Research Plan.
1Records. Each Party shall maintain, and cause its Affiliates and Sublicensees and Third Party Contractors to maintain, in good scientific manner, complete and accurate books and records pertaining to its activities under each Research Program, in sufficient detail to verify compliance with its obligations under this Agreement, and shall ensure that such books and records (a) are appropriate for patent and regulatory purposes, (b) are kept and maintained in compliance with Applicable Law, and (c) properly reflect all work done and results achieved in the performance of activities under each Research Program. Such books and records shall be retained by each Party for at least [**] after the expiration or termination of this Agreement in its entirety or for such longer period as may be required by Applicable Law. Each Party shall have the right, during normal business hours and upon reasonable notice, to inspect and copy all such records of the other Party.
1Records. Pfizer agrees to keep, and to require its Affiliates and Sublicensees to keep, full, clear and accurate records for a minimum period of [**] after the relevant payment is owed pursuant to this Agreement, setting forth as applicable the sales and other disposition of Licensed Products sold or otherwise disposed of, in sufficient detail to enable royalties and compensation payable to Voyager hereunder to be determined.
1Records. For a period not less than six (6) years following each Royalty Payment Date, Licensee shall keep, and shall insure that its Sublicensees shall keep, such books and records as are sufficient to verify the correctness of all amounts payable on such date, including without limitation inventory, sales and invoice records, general ledgers, financial statements and tax returns of Licensee, its Sublicensees and their Affiliates as relate to the Licensed Products.
